Anecortave acetate (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anecortave acetate" in English language version.

refsWebsite

Global rank English rank

2^nd place

2^nd place

4^th place

4^th place

274^th place

309^th place

1clinicaltrials.gov

5,225^th place

4,062^nd place

399^th place

333^rd place

572^nd place

436^th place

1businesswire.com

615^th place

407^th place

low place

low place

alcon.com

"Alcon Official Site: Developing Innovative Eye Care Treatments". Alcon.com. Retrieved 16 March 2022.

businesswire.com

"News". Businesswire.com (Press release). Retrieved 16 March 2022.

clinicaltrials.gov

"Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) Versus Sham Administration in Singaporean Patients at Risk for Progressing to Exudative Age-Related Macular Degeneration (AMD)". Clinicaltrials.gov. 27 November 2012.

doi.org

Robin AL, Suan EP, Sjaarda RN, Callanan DG, Defaller J (February 2009). "Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma". Arch. Ophthalmol. 127 (2): 173–8. doi:10.1001/archophthalmol.2008.595. PMID 19204235.
Reid JG, Debiak-Krook T (1990). "Corticoids from 17-oxosteroids". Tetrahedron Lett. 31 (26): 3669–3672. doi:10.1016/S0040-4039(00)97440-9.
Kaiser PK, Goldberg MF, Davis AA (January 2007). "Posterior juxtascleral depot administration of anecortave acetate". Surv Ophthalmol. 52 (Suppl 1): S62–9. doi:10.1016/j.survophthal.2006.10.015. PMID 17240258.

drugs.com

"Alcon Receives FDA Decision on Retaane Suspension for Wet AMD". Drugs.com. 2007-09-24.

nih.gov

pubmed.ncbi.nlm.nih.gov

Robin AL, Suan EP, Sjaarda RN, Callanan DG, Defaller J (February 2009). "Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma". Arch. Ophthalmol. 127 (2): 173–8. doi:10.1001/archophthalmol.2008.595. PMID 19204235.
Kaiser PK, Goldberg MF, Davis AA (January 2007). "Posterior juxtascleral depot administration of anecortave acetate". Surv Ophthalmol. 52 (Suppl 1): S62–9. doi:10.1016/j.survophthal.2006.10.015. PMID 17240258.

sec.gov

"Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration" (PDF). Sec.gov. Retrieved 16 March 2022.

springer.com

adisinsight.springer.com

[1] ^{[dead link‍]}